02:30 , May 7, 2015 |  BC Extra  |  Top Story

Alexion to acquire Synageva

Synageva BioPharma Corp. (NASDAQ:GEVA) soared $107.52 (112%) to $203.39 on news that Alexion Pharmaceuticals Inc. (NASDAQ:ALXN) will acquire the company for $115 in cash and 0.6581 Alexion shares per Synageva share, or about $9 billion...
08:00 , Jan 2, 2012 |  BioCentury  |  Finance

Small-fry squashed

Among last year's best-performing large cap biotechs were an acquiree and an acquirer: HCV play Pharmasset Inc. and Valeant Pharmaceuticals International Inc. Other big cap stocks also did well overall, while investors abandoned their small-...
07:00 , Aug 20, 2007 |  BC Week In Review  |  Company News

Aeterna Zentaris management update

Aeterna Zentaris Inc. (TSX:AEZ;AEZS), Quebec City, Quebec   Business: Endocrine, Infectious, Cancer   Hired: Paul Blake as SVP and CMO, formerly CMO of Avigenics Inc.  ...
07:00 , May 9, 2005 |  BioCentury  |  Tools & Techniques

Biopharming LEXicon

Production of proteins in plants or animals each provides advantages over protein production in mammalian cells or E. coli, including the capacity to economically scale up and express complex proteins. However, no products produced this...
08:00 , Feb 9, 2004 |  BC Week In Review  |  Company News

AviGenics, Chromos deal

AviGenics exclusively licensed CHR's ACE System to generate transgenic avians for protein therapy development. AviGenics will use the technology with its own Avian Transgenesis System to develop transgenic hens that produce therapeutic proteins in their...
07:00 , Aug 11, 2003 |  BC Week In Review  |  Company News

AviGenics other research news

AviGenics's human interferon alpha-2b produced from transgenic chicken eggs showed a protein sequence and glycosylation pattern equivalent to that of naturally produced human interferon. The transgenic chickens showed consistent production of the protein over 3...
07:00 , Apr 14, 2003 |  BC Week In Review  |  Company News

AviGenics management update

AviGenics Inc. , Athens, Ga.   Business: Agbio/Environmental/Veterinary   Hired: Yashwant Deo as CEO, president and a director, formerly SVP of operations at Medarex Inc. ; he replaces Carl Marhaver, who becomes COO  ...
07:00 , Apr 7, 2003 |  BC Extra  |  Company News

Deo joins AviGenics as CEO

Agbio company AviGenics (Athens, Ga.) hired Yashwant Deo as president, CEO and a director. Deo previously was SVP of operations at antibody company Medarex (MEDX). He replaces Carl Marhaver, who will become COO....
07:00 , Jul 29, 2002 |  BC Week In Review  |  Company News

AviGenics, Roslin Institute, Viragen biomanufacturing news

The parties resolved all suits, which VRA said is related to claims made by AviGenics that VRA, Roslin and Helen Sang, a scientist at Roslin, misappropriated trade secrets and information regarding avian transgenic technology belonging...
07:00 , Apr 8, 2002 |  BC Week In Review  |  Company News

AviGenics other research news

Researchers published in Nature Biotechnology the use of a replication-deficient retroviral vector to insert the beta-lactamase gene into chickens. The protein was secreted in chickens' serum and egg white and gave similar expression levels through...